(Q79369807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

title

T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

transitional cell carcinoma

22 December 2019

main subject

1 reference

M Peyromaure

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

M Zerbib

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

93

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

60-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Intravesical bacillus Calmette-Guérin treatment for Stage T1 grade 3 transitional cell carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Recurrence and progression in stage T1G3 bladder tumour with intravesical bacille Calmette-Guérin (Danish 1331 strain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Tumour progression and survival in patients with T1G3 bladder tumours: 15-year outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Transurethral resection and sequential chemo-immunoprophylaxis in primary T1G3 bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Treatment of high-risk superficial bladder cancer with maintenance bacille Calmette-Guérin therapy: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Long-term maintenance bacille Calmette-Guérin therapy in high-grade superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

Superficial bladder cancer T1G3: the choice of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2004.04556.X

10.1111/J.1464-410X.2004.04556.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14678369%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference